NEW YORK, Aug. 3 – Biotech holding company Techne has acquired a 39 percent interest in Discovery Genomics and rights to develop antibodies and immunoassays for proteins targets that Discovery Genomics discovers, Techne said on Friday.

The agreement allows Techne exclusively to sell products based on Discovery Genomics’ discoveries in the research market royalty-free. Techne may also opt to sell similar products in the diagnostic market with obligations to pay royalties to Discovery Genomics.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.